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ABSTRACT 
 The aim of this study was to analyse relationship between changes of the stroma 
and expression of tenascin-C and laminin in prostate carcinoma. Tenascin-C 
immunostaining was increased, and laminin decreased in carcinomas compared with 
peritumoral tissue and benign prostate hyperplasia (p<0.05). Statistical analysis 
confirmed connection between stromal changes and tenascin-C expression in prostate 
carcinoma (p<0.05). Gleason pattern 3 carcinomas showed more pronounced stromal 
reaction and tenascin-C expression compared with Gleason pattern 4 carcinomas 
(p<0.05). The main cells in prostate cancer stroma are myofibroblasts that are also 
responsible for tenascin production. Degradation of laminin was not connected with 
myofibroblastic stromal changes.  
 
Key words: myofibroblasts, tenascin-C, laminin, prostate adenocarcinoma 
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INTRODUCTION 
It is well established that reciprocal interactions between prostate stromal cells 
and prostate epithelial cells are central to mechanisms of prostate gland development 
and differentiation.1 Prostate adenocarcinoma has been shown to induce a stromal 
reaction that is associated with changes of stromal cells phenotype as a component of 
tumour progression and spread. Prostate cancer-reactive stroma is composed of a 
myofibroblast/fibroblast mix with a significant decrease of fully differentiated smooth 
muscle, whereas in normal prostate stroma is predominantly consisting of smooth 
muscle.2,3 Myofibroblasts typically appear at sites of pathologic tissue remodelling and 
their phenotype is considered to be intermediate between fibroblasts and smooth muscle. 
Hence, myofibroblasts could be immunohistochemically distinguished by coexpression 
of vimentin and α-smooth muscle actin (α-SMA) without expression of desmin or 
calponin.4-6 Recent investigations have shown that the stromal reaction was more 
pronounced in Gleason pattern 3 compared to other Gleason pattern tumors.2,3 
 To become invasive, prostate cancer cell must first penetrate acinar basement 
membrane (BM) proteins and extracellular matrix adhesive glycoproteins.5 Structural 
components of the BM are laminins, type IV and type VII collagens, nidogens, and 
proteoglycans.6  
 Laminins are heterotrimeric molecules made up by one α, one β and one γ chain. 
Until today we know of five α-chains, three β-chains and three γ-chains. These chains 
combine into at least 14 different laminins. The distribution of these laminin isoforms 
varies between tissues, but in most BMs more than one laminin is present.7  
 Laminins are associated with a variety of biological activities such as cell 
differentiation, cell shape and movement, maintenance of tissue phenotypes, and 
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promotion of tissue survival and their functions in tumour invasion is under extensive 
research today.7,8  
 Tumour cell invasion is also accompanied by remodelling of extracellular matrix 
(ECM) structures, especially at the invasion front, which is marked by proteolitic 
digestion of pre-existing components and synthesis of new components to form a 
different, tumour-associated ECM that promotes the proliferation, survival and 
migration of tumour cells.9,10  
 It was shown in numerous studies that tenascin-C (TN-C) is an extracellular 
matrix protein highly up-regulated in many different cancers.11  
 Tenascin-C is a large (180–300 kDa), hexameric multidomain glycoprotein 
located mainly in the ECM that is involved in tissue interactions during embryogenesis, 
wound heeling, inflammation and oncogenesis.12 The most prominent function of TN-C 
includes anti-adhesion effects, favouring cell motility and growth promotion. These 
proposed activities suggest a potential role for TN-C in regulation of tumour cells 
proliferation, invasion and metastasis.13,14  
 The aim of this study was to analyse the relationship between changes of the 
stroma and expression of tenascin-C and laminin in prostate carcinoma. 
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MATERIALS AND METHODS 
 Our study group included randomly chosen radical prostatectomy specimens of 
52 patients with prostate adenocarcinoma and 21 patients with benign prostate 
hyperplasia (BPH) as a control group. All slides with tumour that were analyzed 
contained also areas of nonneoplastic prostate tissue. The age range of the patients with 
carcinoma was between 52 and 76 years (median age 65.2), and of the patients with 
BPH between 68 and 87 years (median age 74.4 years). 
 Specimens were fixed in 10% buffered formalin, embedded in paraffin, cut at 5 
µm thickness, and routinely stained with hematoxylin and eosin. The diagnosis of 
adenocarcinoma and benign prostate hyperplasia was histologically confirmed in all 
cases. 
 Immunohistochemical staining for vimentin, desmin, α-SMA and laminin was 
performed following Microwave Streptavidin ImmunoPeroxidase protocol on DAKO 
Tech-MateTM Horizon automated immunostainer (DAKO, Copenhagen, Denmark). We 
used primary monoclonal antibodies to vimentin (clone V9; code M 0725; dilution 
1:50), α-SMA (clone 1A4; code M 0851; dilution 1:50), desmin (clone D33; code M 
0760; dilution 1:100), and laminin (clone 4C7; code M0638; dilution 1:25) (all 
purchased from DAKO, Copenhagen, Denmark). Imunohistochemical staining for 
tenascin-C was performed on NexES Ventana automated immunostainer (Ventana, 
Tucson, United States of America). Primary monoclonal antibody to tenascin-C (clone 
49; dilution 1:100; Novocastra Laboratories, Newcastle, United Kingdom) was used. 
Slides stained with laminin were pretreated with pepsin (DAKO, Copenhagen, 
Denmark) in water bath on 30°C during 25 minutes, and slides stained with tenascin-C 
were pretreated with protease 1 (Ventana, Tucson, United States of America) during 8 
minutes. Pepsin and protease 1 were “ready to use”.  
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 As positive controls we used: myometrium for vimentin (cytoplasmic reaction); 
leiomyoma for α-SMA (cytoplasmic reaction); leiomyoma for desmin (cytoplasmic 
reaction); tonsil for tenascin-C (extracellular reaction) and tonsil for laminin (reaction in 
basal membrane). Removals of the primary antibodies were used as negative control.  
 To evaluate the intensity of vimentin, α-SMA, desmin, laminin, and tenascin-C 
expression in prostate carcinoma, in adjacent peritumourous tissue in same prostate and 
in prostate with BPH, the percentage of positively stained stromal cells was examined in 
ten fields for each antibody under high magnification (400x). Peritumourous tissue was 
defined as stromal tissue immediately adjacent to carcinoma but without 
microscopically visible signs of infiltration with malignant glands. Analyzed regions 
were previously selected on low power magnification and marked on slides by different 
colours. The staining intensity was graded on a scale of 0-3, and expressed as 0, 0% 
positive stromal cells; 1, up to 33% positive stromal cells; 2, 33-66% positive stromal 
cells; 3, more than 66% positive stromal cells.2,3 To compare expression of each 
investigated markers immunohistochemical analysis was performed in previously 
selected areas as stated above, thus all imunohistochemical markers were analyzed in 
same area. The immunohistochemistry results were evaluated by three independent 
observers (DT, MU and BK). 
 Statistical analysis was performed using χ2 test, Fisher’s exact test and 
Spearman’s rank correlation test. Fisher’s exact test was used to compare 0/1 grading to 
2/3 grading for each immunohistochemical marker (vimentin, α-SMA, desmin, 
tenascin-C and laminin) in prostate carcinoma, adjacent peritumourous tissue, and BPH. 
The level of significance was set at p<0.05. 
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 RESULTS 
The Gleason distribution with Gleason patterns is shown in Table 1. The most 
common Gleason pattern was 3. In 48 (92.3%) tumours, one or both pattern was 3.  
Twenty cases (38.5%) had both Gleason patterns 3. The second most common Gleason 
pattern was 4, which was found in 22 (42.3%) cases.  
In analyzed areas 32 (61.5%) adenocarcinomas were Gleason pattern 3, and 20 
(38.5%) were pattern 4. The age range of the patients with carcinoma Gleason pattern 3 
was between 52 and 73 years (median age 65.4), and age range of the patients with 
Gleason pattern 4 was between 54 and 76 years (median age 66.4 years). Statistical 
analysis revealed no significant difference between age of patients with Gleason pattern 
3 and 4 (p=0.62882). 
In 41 (78.9%) patients tumours were confined to prostate (pT2) while 11 
(21.1%) patients had tumour, which extended through prostate capsule (pT3). At the 
time of the diagnosis all patients were without lymph node or distant metastases. 
Immunohistochemical expression of vimentin, α-SMA, desmin, tenascin-C and 
laminin in prostate adenocarcinoma, adjacent peritumourous tissue and BPH is shown 
in Table 2. 
Compared to adjacent peritumourous tissue and BPH, stroma of prostate 
adenocarcinoma showed statistically significant increased vimentin (p=0.00000, 
p=0.00000) and decreased desmin (p=0.00001, p=0.01179) expression whereas 
expression of α-SMA showed no statistically significant difference between all three 
analyzed groups (p>0.05). Peritumourous tissue and BPH showed no statistically 
significant difference in immunohistochemical expression of vimentin and desmin 
(p=0.36196, p=0.62149). 
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Tenascin-C was predominantly expressed in stroma around neoplastic glands 
while laminin was the most increased around benign glands (Fig. 1A-F). Both markers 
were also expressed in wall of medium sized blood vessels, which served as internal 
positive control. However, in only few cases we also noted weak positive tenascin 
reaction in cytoplasm of neoplastic epithelial cells.  
Tenascin-C was significantly increased while laminin was significantly 
decreased in carcinoma compared to adjacent peritumourous tissue and BPH (p<0.05). 
Differences in expression of tenascin-C and laminin in adjacent peritumourous tissue 
and BPH were statistically insignificant (p=0.68194, p=0.73385).  
Spearman’s rank correlation test revealed statistically significant correlation 
between increased vimentin and decreased desmin expression in prostate carcinoma 
(p<0.05) but not in adjacent peritumourous tissue and BPH (p>0.05). In all three 
analyzed groups expression of tenascin-C showed no significant correlation with α-
SMA expression (p>0.05). Expression of laminin did not correlate with expression of 
vimentin, α-SMA and desmin in prostate carcinoma, peritumourous tissue and BPH 
(p>0.05).  
 Immunohistochemical expression of vimentin, α-SMA, desmin, tenascin-C and 
laminin in prostate adenocarcinoma Gleason pattern 3 and 4 is shown in Table 3. 
Fisher’s exact test showed significantly increased vimentin and decreased 
desmin expression in adenocarcinoma Gleason pattern 3 compared to Gleason pattern 4 
(p=0.00452, p=0.03818). The expression of tenascin-C was statistically significantly 
stronger in Gleason pattern 3 (p=0.00003). Expression of α-SMA and laminin was 
similar in both analyzed Gleason pattern (p=0.99999). 
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DISSCUSION  
 Prostate cancer is the most frequent cancer in elderly men, with an increasing 
incidence in industrial countries but exact mechanisms of its appearance and 
progression in not yet entirely known.15 Newest concepts which point out the 
importance of tumourous stroma in tumour development and progression intensified 
investigation of stroma in many tumours, including prostate adenocarcinoma.2,3,16-20  
Reactive stroma in breast and colon carcinoma has been described and in these 
cancers reactive stroma is composed of mixture of myofibroblasts, fibroblasts, 
endothelial cells and immune cells. Although all of these cells could be potentially 
involved in cancerogenesis, myofibroblasts were of special interest.16-18  
Using a co-implantation tumour xenograft model, Orimo et al.18 demonstrated 
that carcinoma-associated fibroblasts (CAFs) extracted from human breast carcinomas 
promoted the growth of admixed breast carcinoma cells significantly more than do 
normal mammary fibroblasts derived from the same patients. The CAFs, which 
exhibited the traits of myofibroblasts, played a central role in promoting the growth of 
tumour cells through their ability to secrete stromal cell-derived factor 1 (SDF-1), which 
stimulated tumour growth directly, acting through the cognate receptor, CXCR4 that is 
expressed by carcinoma cells. CAFs also promoted angiogenesis by recruiting 
endothelial progenitor cells into carcinomas.18  
Martin et al.16 showed that myofibroblasts were accumulated at the invasive 
front of the colorectal carcinomas. Myofibroblasts produced lytic enzymes able to 
degrade the basement membrane surrounding tumour glands, and also participated in 
the synthesis of the ECM components of the tumour stroma, which subsequently altered 
the adhesive and migratory properties of the epithelial colon cancer cells.16  
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 In prostate cancer reactive stroma is mainly composed of myofibroblast and 
fibroblast what has been clearly shown in some previous investigation.2,3 Our current 
study confirmed appearance of myofibroblasts in prostate cancer reactive stroma, 
especially in Gleason pattern 3 tumours, but not in adjacent peritumourous tissue and 
stroma in BPH. Immunohistochemical markers of myofibroblasts were more expressed 
in Gleason pattern 3 compared to Gleason pattern 4 carcinomas. Stromal density in 
Gleason pattern 4 carcinomas was significantly reduced compared to Gleason pattern 3 
carcinomas, but residual stromal cells clearly showed immunohistochemical profile 
toward smooth muscle cells. Tuxhorn et al.3 in their study noted similar results and 
suggested the most pronounced myofibroblastic stromal reaction in Gleason pattern 3 
prostate carcinoma by double-labelled fluorescent immunohistochemistry. 
 Appearance of myofibroblasts in cancer stroma precedes invasive stage of 
cancer; therefore one of main proposed roles of myofibroblasts in cancer progression is 
transition from noninvasive to invasive phenotype. This effect may be mediated directly 
through cell-cell contacts or through diffusible molecules which are produced and 
secreted by myofibroblasts.21,22 They synthesize collagen I and III, fibronectin, versican, 
vascular endothelial growth factors (VEGFs) (especially type VEGF-D), SDF 1 and 
tenascin and also express proteases, fibroblasts activation protein, and matrix 
metalloproteinase’s (MMPs).23,24 
 The role of tenascin in tumours growth and progression is still controversial. 
Some authors have proposed that tenascin was involved in the maintenance of normal 
prostate stromal–epithelial homeostasis and protected against the effects of neoplasia.25 
This opinion is supported by studies which showed that tenascin was secreted by 
stromal cells (fibroblasts/myofibroblasts), but not by prostate cancer cells.25-27 Another 
view of tenascin expression in prostate carcinoma is that as a part of a reactive stroma 
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compartment, it could enhance tumour progression by stimulating angiogenesis, and by 
promoting cancer cell survival, proliferation, and invasion.3  
In our current study tenascin-C was mainly expressed in stroma of carcinoma 
compared to adjacent peritumourous tissue and BPH. When we compared two analyzed 
Gleason patterns, stromal components in Gleason pattern 3 carcinomas showed 
significantly more intense tenascin expression than in Gleason pattern 4 carcinomas.  
 Xue et al.25 in their study showed similar results and confirmed increased 
tenascin-C expression in the ECM, mainly at the periphery of the glands, in tumour foci 
and blood vessels. Low- and moderate-grade tumours were characterized by strong 
tenascin expression while high-grade tumours had sparse tenascin staining. In normal 
glands and hyperplastic lesions tenascin was also weakly expressed.25  
 The same author in another study noted increase of tenascin expression from 
low-grade prostate intraepithelial neoplasia (PIN), where tenascin expression was 
similar to normal glands and BPH to high-grade PIN where tenascin expression was 
high and partly overlapped that of well to moderately differentiated prostate 
carcinoma.28 
 Statistical analysis of our results showed that increased tenascin-C expression 
positively correlated with expression of myofibroblastic and negatively correlated with 
expression of smooth muscle immunohistochemical markers. Tenascin-C was also more 
increased in carcinomas with more prominent stromal reaction (Gleason pattern 3) 
compared to carcinomas with less prominent (Gleason pattern 4) stromal changes. 
These findings directly and indirectly confirmed the role of myofibroblasts in tenascin-
C expression and proposed myofibroblasts as primary origin of tenascin-C in prostate 
carcinoma reactive stroma. 
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 Our results are consistent with results reported by Tuxhorn and co-workers.3 In 
their study myofibroblasts were also more numbered in Gleason pattern 3 prostate 
carcinomas and in all cases strong periglandular tenascin expression was shown. 
However, they studied tenascin expression on 7 cases of Gleason pattern 3 prostate 
carcinomas only. The same authors in the same study confirmed that overexpressed 
transforming growth factor-1 in PIN epithelial cells was capable of inducing HPS-TZ1A 
human prostate fibroblasts to transdifferentiate in the myofibroblasts and express 
tenascin in vitro. 
Recent investigations indicated that one of the most important processes during 
prostate cancer cells migration is laminin degradation by MMP, especially membrane 
type-1 MMP (MT1-MMP). MT1-MMP is a transmembrane member of the MMP 
family that has been demonstrated to be upregulated in prostate cancer cells as cancer 
progresses from normal to prostate intraepithelial neoplasia and to invasive cancer, 
suggesting their potential role in the invasion of prostate cancer.29,30 However, it is also 
well known that some types of proteases and MMPs are synthesized and secreted by 
myofibroblasts.31-33 
Expression of laminin in tumourous stroma was investigated in many tumours 
and loss of laminin has been connected with poor prognosis in colon, urinary bladder 
and pancreas cancers.34-36 
In prostate, laminin types in BM were changing during prostate development 
and different types were observed in prepubertal, adult benign and malignant prostate 
glands.37  
Few other previous investigations showed decreased and disordered laminin 
expression in prostate carcinoma compared to benign glands.25,29,30,37-40 Laminin was 
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also poorly expressed around glands with PIN, and especially accentuated loss of 
laminin was noted in cases with increased tenascin expression.25 
Current study confirmed results of previous investigations of laminin expression 
in prostate carcinoma.25,29,30,37-40 Laminin was decreased in carcinoma compared to 
adjacent peritumourous tissue and BPH while peritumourous tissue and BPH showed 
similar pattern of laminin expression. We found no differences in laminin expression 
between Gleason pattern 3 and 4 carcinomas. Unlike tenascin-C, expression of laminin 
showed no significant correlation with expression of myofibroblastic 
immunohistochemical markers thus it seems that degradation of laminin is not 
dependent to myofibroblastic stromal changes and could be probably due to MMP 
produced by cancer cells. 
 In conclusion, we confirmed that the reactive stroma that occurs in prostate 
carcinomas is different from stroma in adjacent peritumourous tissue and BPH. Gleason 
pattern 3 prostate carcinomas showed more pronounced stromal changes compared to 
Gleason pattern 4 carcinomas.  The main cells in this reactive stroma are myofibroblasts 
that are also responsible for tenascin production and secretion.  
 The value of these changes in different Gleason patterns of prostate carcinoma 
for the routine diagnostics should be further analysed, especially in needle core 
biopsies. 
  
 
 
 
 
 
 14 
Acknowledgment: This work was supported by grants 0108001/02 (B.K.) and 
0134002/02 (M.B.) from Ministry of Science and Technology, Republic of Croatia 
 15 
REFERENCES 
1. Hayward SW, Cunha GR, Dahiya R. Normal development and carcinogenesis of 
the prostate. A unifying hypothesis. Ann NY Acad Sc 1996; 784: 50-62. 
2. Tomas D, Kruslin B. The potential value of (myo)fibroblastic stromal reaction in 
the diagnosis of prostatic adenocarcinoma. Prostate 2004; 61: 324-331. 
3. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive 
stroma in human prostate cancer: Introduction of myofibroblast phenotype and 
extracellular matrix remodeling. Clin Caner Res 2002; 8: 2912-2923. 
4. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic 
cells: expression of cytoskeletal proteins as marker of phenotypic modulations. 
Lab Investi 1990; 63: 144-161. 
5. Kammerer R, Ehret R, von Kleist S. Isolated extracellular matrixbased three-
dimensional in vitro models to study orthotopically cancer cell infiltration and 
invasion. Eur J Cancer 1998; 34: 1950–1957. 
6. Merker HJ. Morphology of the basement membrane. Microsc Res Tech 1994;  
28: 95–124. 
7. Patarroyo M, Tryggvason K, Virtanen I. Laminin isoforms in tumor invasion, 
angiogenesis and metastasis. Semin Cancer Bio. 2002; 12: 197–207. 
8. Colognato H, Yurchenco PD. Form and function: the laminin family of        
heterotrimers. Dev Dyn 2000; 218: 213–234. 
9. Pupa SM, Menard S, Forti S, Tagliabue E. New insight into the role of 
extracellular matrix during tumor onset and progression. J Cell Physiol. 2002; 
192: 259-267. 
10. Sounni NE, Noel A. Membrane type-matrix metalloproteinase and tumor 
progression. Biochimie 2005; 87: 329-342. 
 16 
11. Chiquet-Ehrismann R. Tenascin and other adhesion-modulating proteins in 
cancer. Semin Cancer Biol 1993; 4: 301-310. 
12. Erickson HP. Tenascin-C, tenascin-R, and tenascin-X: a family of talented 
proteins in search of their functions. Curr Opin Cell Biol 1993; 5: 869-876. 
13. Orend G. Potential oncogenic action of tenascin-C in tumorigenesis. Int J 
Biochem Cell Biol 2005; 37: 1066-1083. 
14. Vollmer G. Biologic and oncologic implications of tenascin-C/hexabrachion 
proteins. Crit Rev Oncol/Hematol 1997; 25: 187-210. 
15. De Marzo AM, Nelson WG, Isaacs WB, Epstein JI. Pathological and molecular 
aspects of prostate cancer. Lancet 2003; 361: 955-964. 
16. Martin M, Pujuguet P, Martin F. Role of stromal myofibroblasts infiltrating 
colon cancer in tumor invasion. Pathol Res Pract 1996; 192: 712-717. 
17. Noel A, Foidart JM. The role of stroma in breast carcinoma growth in vivo. J 
Mammary Gland Biol Neoplasia 1998; 3: 215-225. 
18. Orimo A et al. Stromal fibroblasts present in invasive human breast carcinomas 
promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 
secretion. Cell 2005; 121: 335-348. 
19. Rowley DR. What might a stromal response mean to prostate cancer 
progression?  Cancer Metastasis Rev 1998; 17: 411-419. 
20. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer 
progression. J Urol 2001; 166: 2472-2483. 
21. Gabbiani G. The myofibroblasts in wound healing and fibrocontractive diseases. 
J Pathol 2003; 200: 500-503. 
22. Wever DO, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 
2003; 200: 429-447. 
 17 
23. Orimo A et al. Cancer-associated myofibroblasts   possess various factors to 
promote endometrial tumor progression. Clin Cancer Res 2001; 7: 3097-3105. 
24. Orlandini M, Oliveiro S. In fibroblasts VEGF-D expression is induced by cell-
cell contact mediated by cadherin-11. J Biol Chem 2001; 276: 6576-6581.  
25. Xue Y et al. Expression of periglandular tenascin-C and basment membrane 
laminin in normal prostate, benign prostatic hyperplasia and prostate carcinoma. 
Br J Urol 1998; 81: 844-851. 
26. Ibrahim et al. Tenascin expression in prostatic hyperplasia, intraepithelial 
neoplasia, and carcinoma. Hum Pathol 1993; 24: 982-989. 
27. Slater MD, Lauer C, Gidley-Baird A, Barden JA. Markers for the development 
of early prostate cancer. J Pathol 2003; 199: 368-377. 
28. Xue Y et al. Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): a 
marker of prognosis? Anticancer Res 1998; 18: 2679-2684. 
29. Bair EL et al. Membrane type 1 matrix metalloprotease cleaves laminin-10 and 
promotes prostate cancer cell migration. Neoplasia 2005; 7: 380-389. 
30. Udayakumar TS et al. Membrane type-1-matrix metalloproteinase expressed by 
prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell 
migration. Cancer Res 2003; 63: 2292-2299. 
31. Koyama S. Coordinate cell-surface expression of matrix metalloproteinases and 
their inhibitors on cancer-associated myofibroblasts from malignant ascites in 
patients with gastric carcinoma. J Cancer Res Clin Onco 2005; 23: 1-6. 
32. Ottino P, He J, Axelrad TW, Bazan HE. PAF-induced furin and MT1-MMP 
expression is independent of MMP-2 activation in corneal myofibroblasts. Invest 
Ophthalmol Vis Sci 2005; 46: 487-496. 
 18 
33. Yasui H, Andoh A, Bamba S, Inatomi O, Ishida H, Fujiyama Y. Role of 
fibroblast growth factor-2 in the expression of matrix metalloproteinases and 
tissue inhibitors of metalloproteinases in human intestinal myofibroblasts. 
Digestion 2004; 69: 34-44. 
34. Hindermann W, Berndt A, Haas KM, Wunderlich H, Katenkamp D, Kosmehl H. 
Immunohistochemical demonstration of the gamma2 chain of laminin-5 in 
urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis. 
Cancer Detect Prev 2003; 27: 109-115. 
35. Linder S, Castanos-Velez E, von Rosen A, Biberfeld P. Immunohistochemical 
expression of extracellular matrix proteins and adhesion molecules in pancreatic 
carcinoma. Hepatogastroenterology 2001; 48: 1321-1327. 
36. Murai S, Umemiya T, Seiki M, Harigaya K. Expression and localization of 
membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain 
during colorectal carcinoma tumor progression. Virchows Arch 2004; 445: 271-
278. 
37. Brar PK, Dalkin BL, Weyer C, Sallam K, Virtanen I, Nagle RB. Laminin alpha-
1, alpha-3, and alpha-5 chain expression in human prepubertal [correction of 
prepubetal] benign prostate glands and adult benign and malignant prostate 
glands. Prostate 2003; 55: 65-70. 
38. Davis TL, Cress AE, Dalkin BL, Nagle BL. Unique expression pattern of the 
alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate 2001; 
46: 240-248. 
39. Hao J, Jackson L, Calaluce C, McDaniel K, Dalkin BL, Nagle RB. Investigation 
into the mechanism of the loss of laminin 5 (α3β3γ2) expression in prostate 
cancer. Am J Pathol 2001; 158: 1129-1135. 
 19 
40. Hao J, Yang Y, McDaniel K, Dalkin BL, Cress AE, Nagle RB. Differential 
expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and 
normal prostate. Am J Pathol 1996; 149: 1341-1349. 
 
 
 
 
 
 20 
TABLE 1. Distribution of Gleason patterns and scores in 52 patients with prostate 
adenocarcinoma 
 
 
 
            
52 100
7 (4+3) 8 15.4
Total
6 (4+2) 3 5.8
7 (3+4) 10 19.2
6 (2+4) 1 1.9
6 (3+3) 20 38.5
Gleason patterns with 
scores Number of cases %
5 (3+2) 10 19.2
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TABLE 2. Immunohistochemical expression of stromal markers, tenascin-C and 
laminin in prostate adenocarcinoma, peritumourous tissue and benign prostate 
hyperplasia 
 
Fisher's exact test was used to compare 0/1 grading to 2/3 grading in prostate 
adenocarcinoma, peritumourous tissue and benign prostate hyperplasia. 
 
 
 
Legend:  
0 – 0% stromal cells 
1 – up to 33% positive stromal cells 
2 – 33% to 66% positive stromal cells 
3 – more than 66% positive stromal cells 
LamininVimentin SMA Desmin Tenascin-C
8 (15.4%)
44 (84.6%)
4 (19.0%)
17 (81.0%)
47 (90.4%)
5 (9.6%)
18 (85.7%)
3 (14.3%)
3 (5.8%)
49 (94.2%)
2 (9.5%)
19 (90.5%)
4 (7.7%)
48 (92.3%)
0 (0%)
21(100%)
38 (73.1%)
14 (26.9%)
18 (85.7%)
3 (14.3%)
Peritumourous tissue 
(n=52)
0/1
2/3
Benign prostate 
hyperplasia (n=21)
0/1
2/3
50 (96.2%) 30 (57.7%) 34 (65.4%) 1 (1.9%)
0/1
2/3
Prostate 
adenocarcinoma 
(n=52) 38 (73.1%)
14 (26.9%) 2 (3.8%) 22 (42.3%) 18 (34.6%) 51 (98.1%)
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TABLE 3. Immunohistochemical expression of stromal markers, tenascin-C and 
laminin in prostate adenocarcinoma Gleason pattern 3 and 4 
 
4 (20.0%) 14 (70.0%) 20 (100%)
2/3 10 (50.0%) 19 (95.0%) 16 (80.0%) 6 (30.0%) 0 (0%)
Gleason pattern 4 
(n=20)
0/1 10 (50.0%) 1 (5.0%)
31 (96.9%) 14 (43.8%9 28 (87.5%) 1 (3.1%)
Laminin
Gleason pattern 3 
(n=32)
0/1 4 (12.5%) 1 (3.1%) 18 (56.2%) 4 (12.5%) 31 (96.9%)
2/3 28 (87.5%)
Vimentin SMA Desmin Tenascin-C
 
 
Fisher's exact test was used to compare 0/1 grading to 2/3 grading in prostatic 
adenocarcinoma Gleason pattern 3 and 4. 
 
 
 
 
 
Legend:  
0 – 0% stromal cells 
1 – up to 33% positive stromal cells 
2 – 33% to 66% positive stromal cells 
3 – more than 66% positive stromal cells 
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TITLES AND LEGENDS TO FIGURE 
FIGURE 1. Immunohistochemical expression of tenascin-C and laminin in prostate 
carcinoma, adjacent peritumourous tissue and benign prostate hyperplasia. 
Tenascin-C was significantly elevated in prostate carcinoma (A) compared to adjacent 
peritumourous tissue (B) and benign prostate hyperplasia (BPH) (C). Expression of 
laminin was low in prostate carcinoma (D) while adjacent peritumourous tissue (E) and 
BPH (F) showed high laminin expression. (All microphotographs were made under high 
magnification, 400X.) 
  
  
  
